Subscription Agreements in the Pharmaceuticals Industry

220 Contracts & Agreements

Browse by Company

60 DEGREES PHARMACEUTICALS, INC. (3 contracts)
Acer Therapeutics Inc. (6)
ACHILLION PHARMACEUTICALS INC (2)
Acreage Holdings, Inc. (1)
Adamis Pharmaceuticals Corp (1)
ADIAL PHARMACEUTICALS, INC. (1)
AEOLUS PHARMACEUTICALS, INC. (1)
Aerpio Pharmaceuticals, Inc. (2)
Akers Biosciences, Inc. (2)
Akorn (1)
Amphastar Pharma (7)
Ampio Pharmaceuticals, Inc. (1)
ANI Pharma Inc (2)
Anthera Pharmaceuticals Inc (4)
Applied BioSciences Corp. (3)
APRICUS BIOSCIENCES, INC. (1)
ARIAD PHARMACEUTICALS INC (1)
ARTELO BIOSCIENCES, INC. (3)
AYTU BIOSCIENCE, INC (2)
Bespoke Extracts, Inc. (1)
Big Rock Partners Acquisition Corp. (3)
BIODELIVERY SCIENCES INTERNATIONAL INC (1)
BioPharmX Corp (5)
Blue Water Acquisition Corp. (1)
BODY & MIND INC. (1)
Boston Therapeutics, Inc. (5)
Canopy Growth Corp (3)
Cantabio Pharmaceuticals Inc. (1)
CARDAX, INC. (2)
Celexus, Inc (2)
Charlotte's Web Holdings, Inc. (1)
Citius Pharmaceuticals, Inc. (1)
CLS Holdings USA, Inc. (8)
Cocrystal Pharma, Inc. (4)
ContraVir Pharmaceuticals, Inc. (1)
CorMedix Inc. (3)
Eloxx Pharmaceuticals, Inc. (1)
Exactus, Inc. (3)
EYENOVIA, INC. (2)
FRONTIER OILFIELD SERVICES INC (2)
GB SCIENCES INC (1)
GREEN HYGIENICS HOLDINGS INC. (1)
Green Thumb Industries Inc. (1)
HARROW HEALTH, INC. (2)
Haymaker Acquisition Corp. III (1)
Hoth Therapeutics, Inc. (1)
IDENIX PHARMACEUTICALS INC (1)
Innovive Pharmaceuticals, Inc. (2)
IntelGenx Technologies Corp. (4)
Jaguar Health, Inc. (1)
JAVELIN PHARMACEUTICALS, INC (2)
Jazz Pharmaceuticals plc (1)
JUNIPER PHARMACEUTICALS INC (2)
Kedem Pharmaceuticals Inc. (1)
Lev Pharmaceuticals Inc (1)
Lexaria Bioscience Corp. (11)
LIPELLA PHARMACEUTICALS INC (0)
Lotus Pharmaceuticals, Inc. (1)
Lowell Farms Inc. (2)
Luckwel Pharmaceuticals Inc. (4)
Marijuana Co of America, Inc. (1)
MedMen Enterprises, Inc. (1)
MICROCHANNEL TECHNOLOGIES CORP (1)
MYnd Analytics, Inc. (10)
NewBridge Global Ventures, Inc. (1)
NURX PHARMACEUTICALS, INC. (3)
OMEROS CORP (1)
OSCIENT PHARMACEUTICALS CORP (1)
Panacea Acquisition Corp (1)
Phoenix Life Sciences International Limited. (2)
PLAYERS NETWORK (10)
Profile Solutions, Inc. (1)
PROVECTUS BIOPHARMACEUTICALS, INC. (4)
Provention Bio, Inc. (3)
Pulmatrix, Inc. (1)
QUANTA INC (4)
RELMADA THERAPEUTICS, INC. (2)
RespireRx Pharmaceuticals Inc. (2)
Roivant Sciences Ltd. (1)
SAVIENT PHARMACEUTICALS INC (1)
SenesTech, Inc. (1)
Shuttle Pharmaceuticals, Inc. (1)
SIGA TECHNOLOGIES INC (1)
Stem Holdings, Inc. (4)
SYNERGY PHARMACEUTICALS, INC. (1)
Synovics Pharmaceuticals (1)
Terra Tech Corp. (1)
TerrAscend Corp. (9)
Textmunication Holdings, Inc. (2)
TherapeuticsMD, Inc. (4)
TITAN PHARMACEUTICALS INC (1)
Vallon Pharmaceuticals, Inc. (1)
VioQuest Pharmaceuticals, Inc. (2)
Vireo Health International, Inc. (0)
Vitality Biopharma, Inc. (2)
VIVUS INC (2)
Zomedica Pharmaceuticals Corp. (1)

Recent Contracts

Subscription Agreement, dated as of November 22, 2024, by and among Eyenovia, Inc., Avenue Venture Opportunities Fund, L.P. and Avenue Venture Opportunities Fund II, L.P (EYENOVIA, INC., Filed With SEC on November 25, 2024)
Form of Subscription Agreement (Acreage Holdings, Inc., Filed With SEC on June 7, 2024)
Form of Subscription Agreement, dated January 18, 2024 (Canopy Growth Corp, Filed With SEC on January 19, 2024)
Third Amendment to Subscription Agreement dated December 29, 2023, by and between the Company and Navy Capital Green Co-Invest Fund, LLC (CLS Holdings USA, Inc., Filed With SEC on January 4, 2024)
Third Amendment to Subscription Agreement dated December 29, 2023, by and between the Company and Navy Capital Green Fund, LP (CLS Holdings USA, Inc., Filed With SEC on January 4, 2024)
Form of Subscription Agreement, dated September 18, 2023 (Canopy Growth Corp, Filed With SEC on September 18, 2023)
Certain confidential information contained in this document, marked by [***], has been omitted because the Company has determined that the information (i) is not material and (ii)... (TerrAscend Corp., Filed With SEC on July 7, 2023)
Certain confidential information contained in this document, marked by [***], has been omitted because the Company has determined that the information (i) is not material and (ii)... (TerrAscend Corp., Filed With SEC on July 7, 2023)
Certain confidential information contained in this document, marked by [***], has been omitted because the Company has determined that the information (i) is not material and (ii)... (TerrAscend Corp., Filed With SEC on July 7, 2023)
Certain confidential information contained in this document, marked by [***], has been omitted because the Company has determined that the information (i) is not material and (ii)... (TerrAscend Corp., Filed With SEC on July 5, 2023)
Certain confidential information contained in this document, marked by [***], has been omitted because the Company has determined that the information (i) is not material and (ii)... (TerrAscend Corp., Filed With SEC on July 5, 2023)
Certain confidential information contained in this document, marked by [***], has been omitted because the Company has determined that the information (i) is not material and (ii)... (TerrAscend Corp., Filed With SEC on July 5, 2023)
Certain confidential information contained in this document, marked by [***], has been omitted because the Company has determined that the information (i) is not material and (ii)... (TerrAscend Corp., Filed With SEC on June 29, 2023)
Certain confidential information contained in this document, marked by [***], has been omitted because the Company has determined that the information (i) is not material and (ii)... (TerrAscend Corp., Filed With SEC on June 29, 2023)
Certain confidential information contained in this document, marked by [***], has been omitted because the Company has determined that the information (i) is not material and (ii)... (TerrAscend Corp., Filed With SEC on June 29, 2023)
Subscription Agreement dated as of October 11, 2017, by and between the Registrant and Avante International Limited (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
Subscription Agreement dated as of October 11, 2017, by and between the Registrant and Avante International Limited (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 3, 2023)
Subscription Agreement, dated November 22, 2022, by and among Eyenovia, Inc., Avenue Venture Opportunities Fund, L.P. and Avenue Venture Opportunities Fund II, L.P (EYENOVIA, INC., Filed With SEC on March 31, 2023)
Subscription Agreement, dated as of October 11, 2022, by and among MLB Advanced Media, L.P. and Charlottes Web Holdings, Inc (Charlotte's Web Holdings, Inc., Filed With SEC on March 23, 2023)
Subscription Agreement, dated February 21, 2023, between Canopy Growth Corporation and Verition Canada Master Fund Ltd (Canopy Growth Corp, Filed With SEC on February 21, 2023)
Subscription Agreement dated as of October 11, 2017, by and between the Registrant and Avante International Limited (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on January 31, 2023)
Subscription Agreement, dated October 21, 2022, by and between the Company and the Investor (Boston Therapeutics, Inc., Filed With SEC on November 10, 2022)
Subscription Agreement by and among TherapeuticsMD, Inc., Sixth Street Specialty Lending, Inc., TOP IV Talents, LLC and TAO Talents, LLC, dated October 28, 2022 (TherapeuticsMD, Inc., Filed With SEC on October 31, 2022)
Subscription Agreement by and among TherapeuticsMD, Inc., Sixth Street Specialty Lending, Inc., TOP IV Talents, LLC and TAO Talents, LLC, dated September 30, 2022 (TherapeuticsMD, Inc., Filed With SEC on October 3, 2022)
Second Amendment to Subscription Agreement, dated September 15, 2022, by CLS Holdings USA, Inc., in favor Navy Capital Green Co-Invest Fund, LLC (CLS Holdings USA, Inc., Filed With SEC on September 21, 2022)
Second Amendment to Subscription Agreement, dated September 15, 2022, by CLS Holdings USA, Inc., in favor Navy Capital Green Fund, LP (CLS Holdings USA, Inc., Filed With SEC on September 21, 2022)
Form of Subscription Agreement (Lowell Farms Inc., Filed With SEC on August 19, 2022)
Subscription Agreement by and among TherapeuticsMD, Inc., Sixth Street Specialty Lending, Inc., TOP IV Talents, LLC and TOA Talents, LLC, dated July 29, 2022 (TherapeuticsMD, Inc., Filed With SEC on August 1, 2022)
Form of Subscription Agreement (Roivant Sciences Ltd., Filed With SEC on June 28, 2022)
Form of Subscription Agreement (Lowell Farms Inc., Filed With SEC on September 3, 2021)
Subscription Agreement, dated June 1, 2021, by and among Dragon SPAC S.p.A., Napo Pharmaceuticals, Inc. and Joshua Mailman (Jaguar Health, Inc., Filed With SEC on June 4, 2021)
Form of Subscription Agreement (Luckwel Pharmaceuticals Inc., Filed With SEC on May 26, 2021)
Subscription Agreement of Parallax Master Fund, L.P. dated May 17, 2021 (MedMen Enterprises, Inc., Filed With SEC on May 17, 2021)
Subscription Agreement, dated May 16, 2021, by and among Aerpio Pharmaceuticals, Inc. and each purchaser identified on Exhibit A thereto (Aerpio Pharmaceuticals, Inc., Filed With SEC on May 17, 2021)
Form of Subscription Agreement (Luckwel Pharmaceuticals Inc., Filed With SEC on April 27, 2021)
First Amendment to Subscription Agreement, dated April 19, 2021, by CLS Holdings USA, Inc. in favor of Darling Capital, LLC (CLS Holdings USA, Inc., Filed With SEC on April 21, 2021)
First Amendment to Subscription Agreement, dated April 15, 2021, by CLS Holdings USA, Inc. in favor of Navy Capital Green Co-Invest Fund, LLC (CLS Holdings USA, Inc., Filed With SEC on April 21, 2021)
First Amendment to Subscription Agreement, dated April 15, 2021, by CLS Holdings USA, Inc. in favor of Navy Capital Green Fund, LP (CLS Holdings USA, Inc., Filed With SEC on April 21, 2021)
Form of Equity Subscription Agreement (Textmunication Holdings, Inc., Filed With SEC on March 18, 2021)
Form of Subscription Agreement (Big Rock Partners Acquisition Corp., Filed With SEC on March 15, 2021)